Stocks/EMN

EMN

Eastman Chemical Company
Basic Materials·Chemicals
$75.87
$8.7B market cap
Claude Rating
4/10UNDERWEIGHT
Revenue
$8.6B
Free Cash Flow
$498.0M
Rev Growth
-4.9%
FCF Margin
5.8%
P/FCF
17.4x
EV/FCF
26.8x
Fwd EV/EBITDA
9.9x
Fair Value
$62.00
Upside
-18.3%

Eastman Chemical Company operates as a specialty materials company in the United States and internationally. The company's Additives & Functional Products segment offers hydrocarbon and rosin resins; organic acid-based solutions; amine derivative-based building blocks; metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators; specialty coalescent, specialty and commodity solvents, paint additives, and specialty polymers; heat transfer and aviation fluids; insolu

2-Year Price History

$74.12-20.6%
$60$70$80$90$100volMay 24Sep 24Jan 25May 25Sep 25Jan 26May 26

Quarterly Financials & Projections

Quarterly Waterfall ($ M)
PeriodRevEBITDAOpInNIOCFFCFCapExCashDebtSharesROICIntCovEV/EBITDA
Est2028-Q12,300391.0--138.0---138.0-92.01,924----------
Est2027-Q42,100336.0--105.0--399.0-88.22,062----------
Est2027-Q32,280392.2--148.2--273.6-91.21,663----------
Est2027-Q22,320389.8--143.8--174.0-92.81,389----------
Est2027-Q12,220355.2--122.1---177.6-93.21,215----------
Est2026-Q42,020292.9--90.9--363.6-90.91,393----------
Est2026-Q32,180344.4--126.4--228.9-93.71,029----------
Est2026-Q22,250348.8--123.8--135.0-101.3800.0----------
Act2026-Q12,177324.0193.0107.0-137.0-240.0-103.0665.05,325114.99.4%6.6x11.2x
Act2025-Q41,973195.0121.0105.0502.0390.0-112.0566.05,077114.97.2%3.8x9.0x
Act2025-Q32,202319.0210.047.0402.0265.0-137.0489.05,075115.48.3%5.7x8.7x
Act2025-Q22,287352.0284.0140.0233.083.0-150.0423.05,126116.215.2%6.3x8.7x
Act2025-Q12,290432.0318.0182.0-167.0-314.0-147.0418.05,021117.914.9%8.2x8.1x
Act2024-Q42,245482.0378.0330.0540.0365.0-175.0837.05,258117.922.1%8.6x9.7x
Act2024-Q32,464460.0357.0180.0396.0275.0-121.0622.05,054117.815.8%8.7x8.1x
Act2024-Q22,363467.0363.0230.0367.0249.0-118.0514.05,033118.618.9%8.7x8.9x
Act2024-Q12,310394.0282.0165.0-16.0-201.0-185.0499.05,080118.214.4%7.4x8.3x
Act2023-Q42,205596.0201.0310.0452.0272.0-180.0548.05,138118.78.1%11.0x7.5x
Act2023-Q32,264378.0261.0178.0514.0278.0-236.0439.05,220119.014.9%6.4x10.6x
Act2023-Q22,322444.0339.0272.0410.0169.0-241.0410.05,437119.620.4%7.8x10.2x
Act2023-Q12,407390.0295.0134.0-2.0-178.0-176.0599.05,650119.713.9%7.1x9.5x
Act2022-Q42,361195.0129.01.0457.0251.0-206.0493.05,151120.56.6%3.8x8.3x
Act2022-Q32,691443.0285.0301.0256.092.0-164.0461.05,065122.317.8%9.8x--
Act2022-Q22,774539.0376.0256.0245.0106.0-139.0456.04,991126.416.0%12.0x--
Act2022-Q12,709452.0281.0235.017.0-98.0-115.0487.05,363130.712.6%9.6x--

AI Analysis

LLM Evaluations

Claude4/10UNDERWEIGHTFV: $62.00

Eastman Chemical is a deteriorating specialty chemical story masquerading as a turnaround. Revenue is declining across all four segments, EBITDA margins have compressed from ~19-20% to ~14-15%, and management's earnings bridge to $5.50-$6.00 relies heavily on cost cuts and utilization recovery rather than organic demand growth. The loss of the DOE grant undermines the circular economy narrative, the Fibers segment is in structural decline (-27% YoY), and Chemical Intermediates is loss-making at the EBIT level due to Chinese export dumping. The 5.4% dividend yield looks attractive but is poorly covered given negative Q1 operating cash flow and heavy reliance on receivables factoring ($648M). With $770M in near-term debt maturities, S&P outlook at Negative, and employee morale deteriorating, the risk/reward skews unfavorably at current levels. The stock needs either a clear macro recovery or successful execution of multiple self-help initiatives simultaneously—a low-probability combination in the current environment.

Catalyst Potential catalysts include: (1) resolution of US-China trade tensions improving CI spreads and removing destocking overhang; (2) successful debottlenecking of Kingsport methanolysis to 130% proving circular economy economics; (3) ETP project completion delivering the promised $50-100M structural earnings improvement; or (4) a broader manufacturing cycle recovery lifting volumes across all segments. On the short side, a dividend cut or credit downgrade would accelerate the decline.
Risk The single biggest risk is that the cost-cutting-driven recovery narrative fails to materialize because macro headwinds persist (tariffs, weak housing/durables, Chinese oversupply), leading to further margin compression, a potential credit downgrade to junk, and an eventual dividend cut that would trigger a significant selloff from the income investor base.
Trend
DETERIORATING
Mgmt
4/10
Quarter
4/10
Exp. Move
-5.0%

Latest Earnings Call

Transcript Summary

Eastman Chemical’s Q1 2026 earnings call highlighted the company's ability to navigate geopolitical volatility and high energy costs through strategic pricing and geographic advantages. CEO Mark Costa emphasized that Eastman's vertically integrated North American assets provide a significant cost and security-of-supply advantage over Asian competitors. The company implemented $500 million in price increases to offset inflation in raw materials like paraxylene and VAM. A core growth driver is the methanolysis circular platform, which is delivering 4-5% revenue growth through wins in cosmetic packaging and rPET partnerships with brands like Pepsi. While the Fibers segment saw a minor guidance cut due to Middle East logistics issues, the Chemical Intermediates segment is benefiting from tight global supply and expanding spreads. Q1 results were bolstered by a $20 million tariff refund that offset winter storm costs. Management remains bullish on a second-half recovery driven by contract commitments and cost-saving initiatives, targeting full-year EPS above $6. Despite weak consumer discretionary demand, Eastman is successfully leveraging innovation to gain market share and maintain price-cost stability, positioning the company for significant margin expansion as global markets stabilize.

Valuation & Metrics

Market Stats

Price$75.87
Market Cap$8.7B
Enterprise Value$13.3B
P/S Ratio1.0x
P/FCF17.4x
EV/FCF26.8x
FCF Margin (TTM)5.8%
FCF Yield5.7%
Dividend Yield (TTM)--
Annual Dilution-2.5%
CurrencyUSD

TTM Financial Snapshot

Revenue$8.6B
Net Income$399.0M
Free Cash Flow$498.0M

Revenue Growth (YoY)-4.9%
EBITDA Margin13.8%
Net Margin4.6%
FCF Margin5.8%
CapEx % of Revenue5.8%
SBC % of Revenue-0.6%
ROIC10.0%
WC Change % Rev1.0%
Interest Coverage5.6x

DCF Fair Value Estimate

$13.13
-82.7% upside
Fair Enterprise Value$6.2B
− Net Debt$4.7B
= Fair Equity$1.5B
Revenue Growth3.8% → 2.0%
FCF Margin5.8% → 9.0%
Discount Rate15.0%
Terminal EV/FCF11.0x

Forward Outlook & Risk

Short Interest

Short % of Float4.2%
Short Shares4.7M
Days to Cover4.0
Change (vs Prior)-7.8%
Short % Float History
4.20%+1.40pp
2.5%3.0%3.5%4.0%4.5%04-3007-1509-1511-1401-1504-30

Options

Call IV (ATM)33%
Put IV (ATM)41%
ATM Spread0.54%
Call $OI (near money)$1.7M
Put $OI (near money)$675K
ATM ExpiryJuly 17, 2026 (56D)
ATM Strike$75.0
Major Expirations4
Near-money chain · July 17, 2026
StrikeCall Bid/AskCall OIPut Bid/AskPut OI
$55.00$17.30/$21.400--/$0.801
$60.00$13.60/$15.800$0.45/$0.7533
$65.00$8.80/$11.203$1.10/$1.3576
$70.00$6.10/$6.8051$2.40/$2.7522
$75.00$3.40/$3.80301$4.80/$5.103
$80.00$1.55/$1.95301$7.90/$8.701
$85.00$0.65/$1.0016$11.00/$13.300
$90.00$0.25/$0.950$15.50/$18.200
Snapshot: 2026-05-22

Forward Projections & Estimates

NTM Revenue Growth+0.4%
Forward FCF Margin6.3%
Forward EBITDA Margin15.5%
Forward P/FCF15.8x
Forward EV/FCF24.3x
Forward Int. Coverage6.5x
Model Risk Score7/10
Bankruptcy Odds4%
Est. Borrow Rate6.8%
Terminal EV/FCF11.0x
LT Growth2.0%
LT FCF Margin9.0%

Employees

Headcount14,000
Revenue / Employee$617,071
Gross Profit / Employee$122,000
2022: 14,500 → 2023: 14,000 → 2024: 14,000 → 2025: 13,000 (-4% CAGR)

Institutional Ownership

Headline & net flow

NET BUYING

In Q1 2026 so far (quarter still filing), institutions are net buyers — bought 12.9% of float, sold 3.0%. 1 filer moved >1% of shares (1 buying, 0 selling).

Net flow · Q1 2026still filing
+9.9% of float (net)
Bought 12.9% · Sold 3.0%
633 filers reported (last quarter: 651)

Ownership composition

Active
59.7%(-14.5% YoY)
612 filers
hedge / family / endowment
Retail funds
Fidelity, Schwab, 401(k)
Passive
26.2%(-11.4% YoY)
6 filers
Vanguard, iShares, SPDR
Market makers
0.0%(-0.1% YoY)
5 filers
Citadel, Susquehanna
Insiders
0.5%
Form 4 — latest per insider
0%25%50%75%100%2022-062023-032023-122024-092025-062026-03
ActiveRetail fundsPassiveMarket makersRetail direct

Top holders

Fund$ valueCost basisΔ QoQΔ YoYα lifeFund AUM
BlackRock, Inc.Passive$1.26B$86.02+$213M+$595M-0.2%$5.69T
DIMENSIONAL FUND ADVISORS LPPassive$377M$72.10+$25.9M+$179M-0.4%$480.92B
Capital Research Global Investors$370M$88.71+$75.4M−$98.0M+0.4%$644.55B
STATE STREET CORPPassive$319M$72.46+$20.9M−$90.5M-0.2%$2.89T
FRANKLIN RESOURCES INC$298M$91.60+$14.1M−$147M-0.2%$403.03B
MORGAN STANLEY$235M$80.50−$19.7M−$77.8M-0.3%$1.65T
MASSACHUSETTS FINANCIAL SERVICES CO /MA/$199M$78.87−$3.5M−$12.8M-0.4%$297.48B
Allspring Global Investments Holdings, LLC$197M$67.09+$55.9M+$190M-0.6%$59.61B
EARNEST PARTNERS LLC$187M$75.82+$3.1M+$14.0M-1.0%$24.25B
BANK OF AMERICA CORP /DE/$171M$79.41+$20.4M−$6.8M-0.1%$1.36T
GEODE CAPITAL MANAGEMENT, LLCPassive$156M$78.67+$4.6M−$66.5M+2.3%$1.61T
TWO SIGMA INVESTMENTS, LP$108M$73.05+$50.3M+$107M-0.7%$117.03B
DAVENPORT & Co LLC$97.3M$69.93+$50.2M+$97.2M-0.2%$17.92B
Bank of New York Mellon Corp$93.0M$79.35−$782K−$4.7M+0.5%$543.21B
LSV ASSET MANAGEMENT$91.7M$67.17−$2.2M−$3.3M+0.0%$46.40B
LETKO, BROSSEAU & ASSOCIATES INC$91.1M$69.10−$82K+$27.8M+0.7%$6.20B
CHARLES SCHWAB INVESTMENT MANAGEMENT INC$90.9M$75.20+$5.3M+$3.8M+1.0%$645.81B
UBS Group AG$90.8M$82.28+$46.9M+$2.1M-0.3%$562.11B
Legal & General Group Plc$89.2M$88.20−$22K+$1.9M-0.1%$432.24B
SEI INVESTMENTS CO$87.6M$74.73+$6.9M+$22.2M-0.4%$108.06B
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.

Trading behavior

Smart-money alpha (lifetime, %/qtr)NEUTRAL
Holders
-0.14%
avg per quarter
Holders (ex-self)
-0.14%
excl. this stock
Buyers (this Q)
-0.09%
291 buyers · $1.81B in
Sellers (this Q)
-0.27%
224 sellers · $0.13B out
alpha coverage: 100% of $ has a lifetime-alpha record
Holder behavior on this stocksource: stock
On big dips (−10%+)
-14.1%
how holders react when this stock falls
On quiet Qs
-13.4%
−10% to +10% baseline
On rallies (+10%+)
-15.5%
how they react when this stock rises
Holders' portfolio flow this Q
+4.0%
inflows — adds are organic
Sellers' portfolio flow this Q
-0.1%
Sellers' overall flow ~ flat.
▸ Compare to holder-profile behavior (across all their stocks)
Holder dip (any stock)
-4.1%
Holder mid (any stock)
-2.0%
Holder rally (any stock)
-3.3%

Top Holders Over Time

5-year share-count history (top 10 holders by peak, incl. exited) + price

08.3M16.6M24.9M33.2M$62$72$83$94$1052021-062022-062023-062024-062025-062026-03
hover the chart for per-quarter detailprice (right axis)
JPMORGAN CHASE & CO153KCapital World InvestorsFRANKLIN RESOURCES INC3.9MCapital Research Global Investors4.8MMORGAN STANLEY3.1MPUTNAM INVESTMENTS LLCNinety One UK LtdInvesco Ltd.691KMASSACHUSETTS FINANCIAL SERVICES CO /MA/2.6MLSV ASSET MANAGEMENT1.2M

Related Stocks

Investors who own this also own

Stocks held by the same active managers as this one, ranked by score — how much more often these appear together than random chance (1× = baseline). Excludes index ETFs and market makers; minimum 3 shared holders.

TickerNameCo-holdersScore
CECelanese Corporation3157.49×
JPMJPMorgan Chase & Co.41.77×

Analyst Coverage

Analyst Coverage
Price Targets
Last Quarter (6 analysts)$83.33980.0%
Last Year (16 analysts)$77.38200.0%
Current Price$75.87

Corporate

Executive Compensation (2023-2025)

Direct Pay$144.5M
Incentive & Other$65.5M
Total Compensation$210.0M
% of Revenue0.8%

Insider Trading (last 12mo)

Open-market only (Form 4 P-Purchase + S-Sale). Excludes grants, option exercises, tax withholding, gifts.
Officers & directors
Buys ($, 12mo)
$120K
1 txn · 1 insider · 1,750 sh
Sells ($, 12mo)
$132K
1 txn · 1 insider · 1,709 sh
Recent transactions
DateSideInsiderTitleSharesPriceDollarsOwned $
2026-05-05SELLHolt Adrian Jamesofficer: SVP, Chf HR Ofcr1,709$77.05$132K$0
2025-08-27BUYSMITH BRIAN TRAVISofficer: EVP, AFP, Mfg., WWEC & HSE1,750$68.34$120K$1.14M

Order Flow (FINRA, ~3w lag)

9.3%retail-0.3pp
34.4%dark+3.2pp
week of 2026-04-27
10%15%20%25%30%35%24-1125-0225-0525-0825-1126-0226-04retail (non-ATS)dark (ATS)
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.

Revenue Breakdown

Revenue Segments

By Product (2026-Q1)
Additives And Functional Products$739.0M+1%
Advanced Materials$715.0M-1%
Chemical Intermediates$495.0M-9%
Fibers$225.0M-22%
By Geography (2022-Q3)
North America$1.2B+0%
EMEA$680.0M-3%
Asia Pacific$662.0M+1%
Latin America$165.0M-1%

Filing Risk Analysis

Filing Risk Scores

Eastman Chemical: Aggressive Factoring and One-Time Gains Mask Operational Deterioration and Cash Flow Deficits

Overall Risk
6/10
Fraud
3/10
Dilution
2/10
Insolvency
4/10
Earnings Overstated
7/10
Hidden Liabilities
5/10
Legal
4/10
Audit Warnings
3/10
Hidden Upside
3/10
Contextually Acceptable
6/10

Counter-Thesis

Counter-Thesis & Recent News

📰 Recent News

In late April 2026, Eastman Chemical reported a Q1 2026 EPS miss of $1.09 (vs. $1.10 expected). This follows a disappointing Q4 2025, where revenue of $1.97 billion missed estimates by roughly $70 million, representing a 12.1% year-over-year decline. In January 2026, RBC Capital downgraded the stock to 'Sector Perform' from 'Outperform,' cutting the price target to $70. Similarly, Wells Fargo downgraded EMN to 'Equal-Weight' in December 2025, citing limited organic growth and high capital expenditure risks (Source: RBC Capital Research, Investing.com, StreetInsider).

🐻 Bear Case

The core bear case centers on a massive disconnect between anemic revenue growth (~1%) and aggressive management forecasts for double-digit earnings growth (~17%). Skeptics argue that profit growth is overly dependent on margin expansion through cost-cutting rather than actual demand. The 'Advanced Materials' segment continues to suffer from weak asset utilization, while the 'Chemical Intermediates' unit reported an EBIT loss in late 2025 due to collapsed spreads and oversupply (Source: Simply Wall St, Seeking Alpha, S&P Global).

🚩 Red Flags

Internal culture and operational stability appear to be deteriorating. Recent employee reviews from April 2026 cite 'terrible upper management,' 'low morale,' and a toxic 'culture shift' that is causing institutional knowledge to leave as experts retire or resign. Financially, S&P Global revised EMN’s outlook to 'Negative' due to rising leverage (FFO-to-debt dropping near 20%) and the unpredictability of tariff-related demand disruptions (Source: Indeed Reviews, Reddit r/ChemicalEngineering, S&P Global Ratings).

⚔️ Competitive Threats

Eastman faces structural headwinds from Chinese exporters who are flooding the 'Chemical Intermediates' market with products priced at or below cash costs to operate. Furthermore, the company’s 'Fibers' segment is losing market share in the acetate tow industry due to global capacity rationalization and increased competition in textiles, leading to a 27% revenue drop in that segment in late 2025 (Source: S&P Global, Investing.com).

💬 Customer Sentiment

Customer demand is characterized by aggressive destocking and caution. In the high-stakes 'Renew' methanolysis line, uptake has been sluggish as customers remain hesitant to pay premiums for sustainable products amidst a weak macro environment. Major end-markets like automotive are expected to decline by low-single digits in 2026, and consumer discretionary customers are holding less safety stock, signaling a lack of confidence in a near-term recovery (Source: StreetInsider, Seeking Alpha Q4 Earnings Call Recap).

Full Earnings Call Transcript

Full Earnings Call Transcript — Q1 • 2026-05-01

Operator: Good day, everyone, and welcome to the First Quarter 2026 Eastman Conference Call. Today's conference is being recorded. This call is being broadcast live on the Eastman website at www.eastman.com. I will now turn the call over to Mr. Greg Riddle, Eastman Investor Relations. Please go ahead, sir.
Greg Riddle: Thank you, Becky, and good morning, everyone, and thanks for joining us. On the call with me today are Mark Costa, Board Chair and CEO; Willie McLain, Executive Vice President and CFO; and Jake LaRoe, Senior Manager, Corporate Analysis and Investor Relations. Yesterday, after market closed, we posted our first quarter 2026 financial results news release and SEC 8-K filing, our slides and the related prepared remarks in the Investors section of our website, eastman.com. Before we begin, I'll cover 2 items. First, during this presentation, you will hear certain forward-looking statements concerning our plans and expectations. Actual events or results could differ materially. Certain factors related to future expectations are or will be detailed in our first quarter 2026 financial results news release during this call, in the preceding slides and prepared remarks and in our filings with the Securities and Exchange Commission, including the Form 10-Q to be filed for first quarter 2026 and the Form 10-K filed for full year 2025. Second, earnings referenced in this presentation exclude certain noncore and unusual items. Reconciliations to the most directly comparable GAAP financial measures and other associated disclosures, including a description of the excluded and adjusted items, are available in the first quarter 2026 financial results news release. As we posted the slides and the accompanying prepared remarks on our website last night, we will now go straight into questions. Becky, please, let's start with our first question.
Operator: We will now take our first question from Vincent Andrews from Morgan Stanley.
Vincent Andrews: Mark, I'm wondering in methanolysis, given what's going on, the run-up in crude oil prices and virgin plastic prices running beyond that, if in methanolysis, this is providing an opportunity for more customer trial or adaptation, whether it's in the U.S. or potentially some export opportunities. Because I seem to remember over the last year or so, we've been talking about customers not wanting to spend or try things that are different, but it would seem to me now your product probably offers some significant relative value beyond just its recycled nature. So if you could comment on that, that would be really interesting.
Mark Costa: So we certainly are very excited about the strength of revenue growth associated with the new platform around methanolysis, both on the specialty side as well as the rPET side. You need to keep in mind that the end markets here, even though there's a lot of stress in the marketplace right now with the Middle East conflict. The end market demand situation hasn't really changed dramatically. Consumer discretionary on durables is still relatively challenged or cosmetics, et cetera. So we're not seeing an uptick in end market demand in this concept. And the customers are still fortunately very focused on the value of renewed content and interested in buying it. So on the specialty side, I don't think anything has really changed. We are getting a bunch of wins. We're seeing a great build in specialty customers. You saw some of that volume growth happen in Q1. It will continue into Q2 and into the back end of the year. And it's happening with Tritan sales and cosmetic packaging where we're seeing the most adoption. On the rPET side, I think there is more of a question around just relative value of our rPET relative to where virgin PET prices are going with the increase in oil. And certainly, that improves the price position of our material relative to those materials that are going up in a considerable way, and so we see strong demand there. But obviously, the demand was strong before oil went up, and we're running our capacity to serve that. And so that 4% to 5% revenue growth that we've talked about in January, we still think that's probably accurate. There may be some upside. The real upside, I think, sits relative to the underlying market sits more in the Middle East-related issue than it is just on the renewed value proposition across the portfolio. But in particular, specialty plastics since we're talking about advanced materials right now, has some upside there. As our competitors in Asia, principally, are facing a much higher oil costs, much higher natural gas costs, they're having to raise prices like we are aggressively in this context. But they're also facing security supply issues. There are shortages out there that's driving all this price increase. So there's -- people are going to start running into the inability to actually make product, polymers, whether it's direct competition or indirect polymer competition. So we're just seeing signs of it, but we expect to see more potential volume upside driven by that operational constraint that's going to be occurring in Asia in particular. So there's a combination of renewed growth for sure. What's impressive in this entire environment is even with the challenges that our customers are facing economically, we're still building. They're still paying premiums for these products, which is a really impressive test of the value proposition.
Operator: Our next question comes from Patrick Cunningham from Citigroup.
Patrick Cunningham: Sort of a related question just on the volume upside as being a reliable supplier here. Have you seen tangible market share gains, particularly in CI at this point? And then you kind of touched on this, but how would you sort of handicap the potential for share upside in other parts of the specialties business as a result of the conflict?
Mark Costa: Yes. So it's a great question, and we're certainly paying a lot of attention to this issue, as I just mentioned. So on the Chemical Intermediates side, certainly, we can sell everything that we can make. And the good news about this year, because we had such large cracker turnarounds last year. We have a lot more volume to sell this year than last year. So we have more volume to sell. Remember, we sell a good amount of that in North America, where we have good margins always. And then we have the export market that we would send material into from chemical intermediates to run the assets full, but those margins have been significantly compressed last year. So those margins now, with the shortage out of the Middle East, have gone up significantly. And so we're going to see the benefit of that. So we see the benefit of a lot more volume than we expected in North America with the tightness in the overall markets from the imports that would have come from Asia that are not coming as much as well as the spreads expanding and a lot more volume to sell. So we're definitely seeing share benefits as well as being exported to higher-value markets like Europe than Asia, where markets are being shorted by material that's not coming from Asia as readily. So lots of different benefits going on there. When it comes to the specialty side, I already hit the point, I think, but we definitely see the potential for volume and market share upside in AFP and Advanced Materials. But we haven't seen a significant amount of improvement yet. So we're -- we think that's still to come. A lot of people are very focused on the price of oil or the price of global natural gas, which is certainly raising the cost structure of our competitors around the world much higher than us. But the quantity shortage, I think, is an impact to the world that we haven't actually seen yet. There are people are living off of a certain amount of inventory, whether it's customers or competitors in serving the market, but that's going to start running out and you're going to start seeing more shortages impacting the markets in addition to just the sort of direct oil or natural gas dynamic.
Patrick Cunningham: Understood. Very helpful. And then just on fibers, you specifically called out reduced customer shipments and some forward-looking volume risk. Can you elaborate what you're seeing there and why the implied second half earnings run rate should still show some improvement year-on-year?
Mark Costa: Sure. So just to sort of go back just a moment to sort of what we're dealing with in Fibers. When the earnings came off last year relative to '24, it was really multiple components. The tow volume is part of the story, but it's important to remember that about $30 million of the decline was textiles, $20 million was sort of stream asset utilization due to weak demand across the company and about $15 million in energy. So when you move to this year, what we told you in January was we thought that the tow volume would be moderately up relative to last year, which was a combination of locking in our contract business with everyone. So we had a modest price decline to lock in our contracts. But our Middle East customers were expected to grow a bit as they were the ones that were missing their contract commitments last year due to the issues we explained about them not realizing market share growth in their markets. And so we were expecting some modest growth in tow from that. Obviously, with the Middle East war happening, those customers have been impacted. We actually have tow there to serve their demand in some warehouses. So it's not an issue of us getting material to them. It's an issue of their ability to operate in this environment and be able to export their cigarettes to other markets because a good portion of their production isn't just for the Middle East, it's for exports to other markets. And so how they get that material out is a bit of a constraint. So Q1 was fine. We see a little bit of risk in Q2 where they're not going to buy quite as much in that quarter as we expected. And the real question is how do they come back in the back half of the year to meet their contract commitments. When it comes to your back half question, the other thing that's going a little bit slower and why we lowered earnings about $20 million in our guide here is the yarn business is not growing as fast in this market context. So we don't see that volume pick up. And as a result, we don't -- we're not getting as much of an asset utilization tailwind as we expected. So when you think about that, we still feel really good about how the business is doing. And then when you look at it from a second half point of view, you have several drivers that will make the second half much better than the first half. First is these contract commitments. So even with our large customers who have signed annual contracts to hold to relatively constant to last year, the contracts allow flexibility in how and when they buy it. And a number of them have chosen to buy less in the first half and buy more in the second half. So you have a pretty significant ramp-up in volume with our core customers around the world, just meeting their contract minimums, which is sort of what we have in this outlook. So that's happening. The second is you've got some continued build in the yarn and film side of things. You will have a little bit of energy tailwind as the energy gets cheaper from a flow-through basis from the winter storm in Q1 to lower natural gas prices going forward. So a number of these factors come together to enable this. And of course, our cost reductions are sort of back-end loaded as well across the company and some of that flows in here.
Operator: Our next question comes from David Begleiter from Deutsche Bank.
David Begleiter: Mark, on CI, if you were to hold spreads steady at today's rates and layer in that $15 million of maintenance tailwind for Q3, what would that mean for Q3 EBIT? Could we see EBIT $100 million in CI in Q3? Or is that too ambitious?
Mark Costa: Well, I think, Dave, we sort of guided you that Q2 would be around $50 million in EBIT with a pretty tight market situation that's going on, obviously, right now. As we look at Q3 and what the trends could be, I would think it's going to be more similar than to be substantially up. I mean, without a doubt, the margins are tight right now and there will be a tailwind from Q2 to Q3 on the shutdown side. But it then comes to your assumptions around when the Strait is going to get opened. If the Strait gets opened in the next month, obviously, some pressure is going to come off in the marketplace, and you'll have spreads moderate a bit. So that makes it a little more complicated to sort of say it's going to be yet. I think it being similar is a reasonable expectation. But it really comes down to how this whole Strait situation plays out and how long the market tightness goes. When you think about it, the price of oil, price of global natural gas are obviously incredibly high right now, and that gives us a very significant advantage in how we make a lot of products, not just olefins, but everything because a lot of our customers are also -- our competitors are based on natural gas, not just for energy, but for feedstock. But if you think about just the cracker side of things on olefins, which is the vast majority of the improvement for us, you've got naphtha offline and you've got methanol offline that's 15%, 20% of that, not just the oil, but these derived products, a lot of time for these refineries to restart. Then you got to get the derivatives restart, then you got to fix the logistics questions. And then you've got damage in places that have to be repaired. All of this says the moderation isn't going to go all the way back to pre-conflict in our minds on oil or the derivatives. But certainly, when the Strait opens, some of that pressure will come off and factor into sort of how the margins trend in the back half of the year. But we feel great about how the business has improved. We're happy to have the cash flow that comes from this business. And we certainly think that it lets us to reset better.
David Begleiter: Very good. And just on the potential volume upside in specialties from these disruptions in Asia, how do you go about making these permanent rather than just temporary?
Mark Costa: That's a great question. So I mean, I think it's going to -- it's unfortunately a dependent answer, David, on where we pick up the volume. In some places where it's a like competitor, the shares may normalize back a bit. But customers are learning painful lessons about exposure and reliable suppliers. And I think one thing to keep in mind is this is an excellent proof point about the advantages of being a North American chemical company. And in particular, being a very vertically integrated chemical company with 80% of our assets in the U.S. gives us a huge cost advantage, but it also gives us a huge security supply advantage to our customers, and there is value to that. And certainly one we intend to take full advantage of in supplying our existing customers, but also picking up new ones that we will intend to hold on to. When we pick up customers, by the way, from other materials, then the chances are we can hold on to them because the value proposition of our product is better once they start using it. Typically, they're using some cheaper polymer like polycarbonate or SAN that doesn't perform as well, but it's cheap. When they switch over to our polymer, they're going to see it perform far better with their consumers and then that should provide some stickiness in how we hold on to that share once they've realized it. So we're going to be doing everything we can. And of course, we're going to be trying to lock the business in on contracts for a longer-term commitment where we can as well in this environment to sort of give us resilience on the volume and the price side.
Operator: Our next question comes from Josh Spector from UBS.
Joshua Spector: Just curious around your visibility around any pull forward or not. I mean, I think in your prepared remarks, you said it's not pull forward, but how are you validating that? I guess all the conversation around potential supply risks from some of your competitors probably makes your customers a bit more nervous and probably build a little bit of inventory. So curious there. And then related with that, just how does this impact your production plans? I think you kept your asset utilization tailwinds kind of the same. I would think if you're anticipating the demand, maybe there could be some upside there. So curious if you could talk about that as well.
Mark Costa: So when we think about the demand pull forward, we're operating with the underlying assumption that end market demand this year is going to be similar to last year, which is the same assumption we gave you at the beginning of the year. And it's the same thing we're using for how we think about planning and assessing what's going on. And in that context, what we're seeing in volume growth in the second quarter sequentially is strengthened growth in the AM business, really especially plastics, which is associated with all the methanolysis wins, which is associated with clear wins of new applications and market share we're getting in our core and Tritan business, our cosmetic business that doesn't have anything to do with pull forward. We don't see a big spike in demand like last year where people are just trying to buy stuff ahead of tariff risk. I think part of what's going on is customers see the risks and want to get ahead of price increases or want to have secure supply, but they're also being cautious about what they do when it comes to building too much demand with market uncertainty that we all can recognize in the back half of the year in this context. And the other factor in this, too, is inventories were really low at the end of last year. So you also have to keep that in mind. That's part of the strength of recovery you saw from Q4 to Q1 as people are starting to rebuild some inventories or, if you will, end of destocking that was going on in Q4. But we don't see a lot of inventory out there in the supply chains at this stage. It's always difficult to see it, to be clear. We certainly, along with the entire industry, have not been experts in understanding the supply chain inventory. But we don't see a lot of build of that, certainly not in March. And as we go through this quarter, our order books are really strong. So we had a good March, a strong March, and we see that continuing in April and May, but June is a wildcard in this market context. We don't see any problems, but we just don't have that much visibility all the way out to June. But overall, there's just no sign of significant market pull-through in the specialties. As I said, in CI, we can sell what we want to make and probably can do that through the end of the year.
Operator: Our next question comes from Frank Mitsch from Fermium Research.
Frank Mitsch: I was struck by the $500 million of price increases that you have started to implement. I'm wondering if you could talk about how you see that phasing in? What has been the initial reactions from your customer base? And how does that match up in terms of your expected inflation in raw materials?
William McLain: Frank, what I would say is, as Mark has already highlighted, in Chemical Intermediates, we were reacting in the moment and driving price increases and volume growth as we think about what's required to supply. In the specialties, obviously, our pricing philosophy has been around the value of our products. And as we pace that with our partners over time. What we expect sequentially is in our specialties, mid-single-digit price increases from Q1 to Q2. When you think about our chemical intermediates, those are phasing in, I would say they're in the high teens or approaching 20% as we see that sequential momentum. So we were -- our teams across the world reacted in the moment in Q1 when March occurred, and we have good progress out of the gate.
Mark Costa: Yes. So just to answer the question around the sort of market competitive dynamics around this. Clearly, everyone is raising prices, whether it's polymers or chemicals across the entire industry. So you have that momentum to leverage being cautious on price increases will accomplish nothing when you're trying to think about consumer demand, except people missing out our margin. I think everyone understands that. So that's point one. Number two is the competitors we have, especially in the specialties, especially in Advanced Materials are Asian-based. They've got significant increase in oil, and they have significant increase in natural gas prices. So their cost structure -- their energy cost structure has gone up more than us. And so they're feeling a lot of pressure to manage their prices. And we're seeing the price increases from our competitors similar to us across the markets. So in this context, we feel pretty good that we can get the price up, hold our volumes. And we've got great commercial teams. We've shown the value of innovation by holding on to price incredibly well in '24 and '25 in very weak market conditions. And now we're in a hyperinflated market condition, and we're showing we can increase our price in our specialties and keep track with our raw material and distribution costs, which is just further proof that we have a specialty business that has differentiated value propositions. And -- but we're always close to our customers. We'll always be keeping an eye on competitive activity and make adjustments if we have to, but we're not seeing the need to do that at this stage.
Frank Mitsch: That's very helpful. And if I could come back and get a clarification. When talking about fibers getting better in the second half of the year, part of that is you have contract commitments from Middle East customers that you're anticipating they're going to meet their contract minimums, et cetera, et cetera. But wouldn't this qualify as force majeure? I mean, wouldn't they be able to say, hey, look, I mean, this -- to me, this seems like the very definition of force majeure. How should we think about that?
Mark Costa: First to frame it, the Middle East customers are about 10% of our revenue in this segment. So the other 90% is predominantly tow as well as some yarn customers. And in that 90%, the real dynamic here is just they all have contracts. They all have volume commitments. Our forecast is based on them buying at the bottom end of the volume range in those contract commitments. And so that's global, has nothing to do with the Middle East. And they bought less in the first half of the year and going to buy more in the back half of the year. And that is the principal driver of the increase in earnings in the second half relative to the first half. And when you get down to the Middle East part, these customers have made a lot of investments in new capacity, and we're winning in the marketplace, but not quite as fast as they wanted. And that's where sort of their volume draw last year sort of came up short. They have taken a bunch of actions to start gaining market share this year and are very focused on doing it. They just have a logistics issue of getting it out. And so we have adjusted our expectations for the risk of that challenge by sort of lowering the earnings expectation of the segment to this $210 million to $240 million range, which is about a $20 million drop. And part of it is just a bit less volume from them, a bit less yarn growth and a bit less asset utilization benefit and you put those 3 together, and that's how you get to that $20 million versus where we were originally. And that's really sort of the dynamic. So it's about customers meeting their contracts. Those customers historically have always met their contracts under any situation, and they don't have a force majeure excuse on that 90%.
Operator: Our next question comes from Matthew DeYoe from Bank of America.
Matthew DeYoe: I can't remember now if it was the slide or the release, but you talked a little bit about the IEEPA tariff refunds. Wondering if that was a tailwind to 1Q or if that's more 2Q? If it was, how much are you expecting to get back there?
William McLain: Matt, on the IEEPA tariffs, obviously, with the Supreme Court ruling and the Court of International Trade, we recognized about $20 million within Q1. That wasn't a tailwind that the IEEPA recognition of the refund was basically in line with the winter storm impact. So you can think about those 2 as being neutralized in Q1. Also, that is the recognition. There's no further IEEPA refunds to recognize. And we would expect to get the cash related to that sometime in the second half of the year.
Matthew DeYoe: Just to clarify, that's been like included in the 1Q results then?
William McLain: Yes, both the winter storm and IEEPA are in the Q1.
Mark Costa: So if you think about how they neutralize each other out, so when we gave you our guide in January, we said this is our outlook, excluding the winter storm impact that we were in the middle of. But by the time we got to the end of the quarter, the tariffs neutralize the winter storm, it turned out to be about the same. So it was just a clean quarter relative to how we guided in January.
Matthew DeYoe: All right. That's helpful. I'm jumping back in. So context is helpful for me. And then on methanolysis, right, I just wanted to, kind of, square some of the commentary because you talk a bit about new wins and on the other side, you're saying demand hasn't really changed much. So can you just kind of refresh where we are on kind of the upscaling here?
Mark Costa: Sure. So when it comes to the revenue of circular, there are 2 components to it, right? There's the core business we have where we're adding recycled content to our Tritan products, our cosmetic products in our specialty businesses and growing those businesses. Obviously, those end market businesses have been very challenged economically from '22 through '25 as a discretionary spend where consumers have pulled back. So the rate of growth we've seen on the specialty side has not been as good as we would have expected in the last couple of years in '24 and '25, in particular, as we were ramping up this plant. The good news is we've been winning some more applications through the back half of last year that are showing up as additional revenue that you saw some of the benefit in Q1, you'll see a build in Q2 and even more so in the back half, on that specialty side with those wins. So to be clear, we're not saying the end market is improving. We're just picking up more market share in durables or in cosmetic packaging with our value proposition. So that's happening. Then on top of that, we swung a line that can make Tritan back to making PET that we explained to you guys a year ago so that we could make PET and serve that rPET market. Pepsi and some others wanted to start buying sooner than their original contract obligations because they saw the value proposition we have with our renew products. So our superior clarity, our superior quality, our superior performance and how the product actually performs was recognized and they wanted to start building and using that material this year. So when you put those 2 together of selling more rPET with Pepsi and with some other packaging companies, brands, you get that 4% to 5% revenue growth that we talked about in January. And when I was answering Vincent's call, I'm just confirming we still see that 4% to 5% growth. But the Middle East conflict hasn't yet significantly increased that to be more than 4% to 5% growth. We can pick up volume for other reasons, as I described, due to sort of impact on competitors. But in this case, we're going to sell what we can make, and we're ramping up rPET capability to sell even more, but it takes a bit of time to do that on the capacity side to continue supporting that growth, not just this year, but also additional growth next year on the rPET side.
Operator: Our next question comes from Jeff Zekauskas from JPMorgan.
Jeffrey Zekauskas: You talked about earning $50 million perhaps in the second quarter and in the third quarter in Chemical Intermediates, but propane prices have really been pretty volatile. Sometimes they're $0.75 a gallon and sometimes they're $0.90 a gallon. How are you handling your propane values? And can you reach these numbers that you're talking about if propane is at $0.90 a gallon?
William McLain: So Jeff, obviously, we're buying propane at the market prices that you're referencing. We do believe here in Q3 -- I'm sorry, in Q2 that we believe that we've appropriately taken that into consideration as we look at the supply-demand balances and how we've priced into the market with our price increases. So yes, there's some range of, as we say, approaching $50 million for the quarter, but we think we've taken that into the appropriate context for $0.75 to $0.90 range.
Jeffrey Zekauskas: Okay. And you talked about for the year, perhaps approaching the cash flow that you generated last year. What are the parts of working capital that are sort of holding your operating cash flow back? Are they payables or receivables or something else?
William McLain: Jeff, what I would say is, as always, the Eastman team does a great job of generating and managing our cash flows, and that was demonstrated again here in Q1 as we think about the level of consumption of cash actually being lower than the prior year. So for Q1 out of the gate, I believe we've got things well managed and under control. As we think about sequentially, we know that we built some inventory in Q1 for our large turnaround, and we expect to deplete that. That's going to be offset with some of the inflation that we've described and have been talking about through the call. At the end of the day, the pressure will come as you think about -- there's pressure on the inventory and on the receivables accounts, but we also think that, that will be mitigated by higher accounts payable at year-end. And we're just trying to look and see what's the second half scenario when we get to midyear as we then think about managing all of the various levers. So under control, the range is narrowed because of the level and magnitude of inflation overall. And as you think about net working capital, you've got 2/3 in your assets and 1/3 in payables. So net tension on that front. That's all we're highlighting at this point.
Operator: Our next question comes from Kevin McCarthy from VRP.
Kevin McCarthy: Mark, can you speak to the expected quarterly earnings cadence in Advanced Materials? It seems like we have a fair number of moving parts there. I'm curious about how you're dealing with paraxylene inflation here and whether you think you can recover or possibly overrecover those sorts of input costs, whether there are any lag effects we should be keeping in mind? And I think you called out some auto production variances there. So maybe you can kind of just kind of walk us through some of those moving parts and think about whether you would expect earnings to do better in the back half versus the second quarter and that sort of thing.
Mark Costa: Sure, Kevin. So when you think about Advanced Materials, there's a cadence, as you said. So first of all, it was great recovery out of Q4 into Q1. Obviously, we had some asset utilization headwinds with some pushes we made there. So as you go into Q2, you've got the benefit of seasonal increase in volumes, the application wins we've talked about, starting with rPET and renewed specialty cross-selling with other products growing, that's going to give us a lift into Q2. The automotive market relative on a year-over-year basis for the year, we're expecting to be sort of down sort of low single digits. So that's -- on a year-over-year basis, it's a bit of a headwind. On a sequential basis, it's a tailwind because the performance film business always has a big ramp-up in volume from Q1 to Q2 that we'll also see helping us on that front. So you have all those factors coming together on the volume side. And then you've got the actions we're taking on price, as you mentioned. So teams have moved incredibly quickly to start implementing prices on either April 1 or May 1 to cover the expected increase in raw material costs of paraxylene and VAM, the key raw materials that go into this segment. And we believe we're very much on track to sort of keep pace with those as we go through the quarter. And then you've got utilization benefits coming in underneath of this that also start to help out. So a number of reasons why we'll certainly have a better sequential quarter in Q2. And then as you look forward into the back half of the year, what you'd expect to see here is continued volume growth because a lot of the build in the circular side is back half loaded. We're going to see continued improvement in just wins in general. So the back half won't have a normal seasonal decline in volume because of all those wins that will offset what is still a normal seasonal decline. So you get volumes that could be flat to a bit better in the back half, which would be not normal, but it makes sense with all the innovation we have in this market context. So you've got that happening. You've got the prices having fully caught up. So you've got a first half to second half sequential tailwind in price cost as that plays out as well as energy coming off a bit. And then you have the cost savings and a lot of the utilization benefit is going to be in the back half, too. So a number of reasons where AM will be stronger than normal in the back half of the year, which is also true of the Fibers business being stronger than normal. And just to finish out the string since we're on the topic, AFP would be normal, right? So it will be normal seasonality in the back half of the year. And then as we just talked about, Chemical Intermediates margins are going to be better in the back half of the year relative to the first half of the year, especially on a Q1 basis relative to the back half. So when you put all that together, that definitely drives earnings to be very attractive in AM to be as we expected as well, holding similar in AFP, CI a lot better this year. Fibers is a bit off. So the overall number means that our earnings per share should be above $6 a share.
Kevin McCarthy: Very helpful. And then secondly, with regard to your Chemical Intermediates segment, how much harder can you run your assets in the second quarter and moving forward relative to the first quarter? Is there a meaningful uplift from utilization? Or is it really all about the more favorable spreads there?
William McLain: So I would just highlight, obviously, we were impacted by some of the winter storm on operations as well. So as we think about going from Q1 to Q2, we'll have -- definitely have that as a tailwind. And also as we look at our olefins and the OXOs from that perspective. I would highlight that we did build some inventory in Q1 for our planned acetyl turnaround. So our acetyl, I'll call it, upside here in Q2 is limited. But for us, we see most of that margin growth coming in our olefins at this stage.
Operator: Our next question comes from John Roberts from Mizuho.
John Ezekiel Roberts: Within the automotive weakness, are you seeing better performance in your coatings ingredients than you're seeing in the films area?
Mark Costa: So no, we're not really seeing a difference. You have to remember, a lot of our demand is driven by the refinish market as opposed to the OEM market on the coatings side. Obviously, that market has been a bit challenged just like the performance films, the aftermarket in general is more discretionary in consumers' behavior that's been true in '24, '25, and we expect that to continue here. And the overall auto market, as I said earlier, is expected to be a little bit soft. And I'd say our demand will be in line with the market on the coating side. And certainly, I think that's not true in the AM side. So we'll continue to do a little bit better than the market with our innovation like HUD and even EVs still take 3x as much material per car versus ICE where there is growth in EVs. And I think some growth in EVs will certainly come back with -- especially in places like Europe and China with the high price of gasoline, you're going to see some people moving back to EVs for economic reasons, maybe even in the U.S., but I would focus more on Europe and China for that. So I think that there's -- those kind of advantages will help us do a little bit better on the interlayer side, performance film side, we will be like coatings more in line with where the market goes.
John Ezekiel Roberts: And then was the winter storm impact and the tariff refund benefit largely booked in the same segments?
William McLain: John, what I would highlight is, obviously, those aren't going to be uniform. And -- but I would say there's not a material difference that I would highlight for you.
Operator: Our next question comes from Mike Sison from Wells Fargo.
Michael Sison: For Chemical Intermediates, can you give us -- can you give me some thoughts what pricing needs to be year-over-year in 2Q to get to the $50 million? And just curious on the delta there in terms of the improvement year-over-year.
William McLain: Yes, Mike, what I highlighted earlier is you can think about the sequential price increases approaching 20% for Chemical Intermediates overall.
Mark Costa: And while we're at it in the specialties, it's about mid-single-digit price increases going on, on the specialty side that gets you to that $500 million.
Michael Sison: Got it. And then it seems like Advanced Materials margins are going to continue -- will improve sequentially in 2Q. This is a segment that I recall used to be at 20%. Is that still the potential for that segment longer term?
Mark Costa: Absolutely. The business is a great business. The main issue that's affecting the margins in Advanced Materials is volume relative to fixed cost. It's not a price -- variable cost issue. The price to variable cost has been good, held up and been incredibly stable, frankly, from 2022 to now. And even now with incredible inflation that we're facing in the business, and across the company, we're implementing prices to keep up with it. So this really -- when you think about AM is more of a utilization-based issue, right? So you've got the underlying cost structure, then we added $100 million of the cost structure for the methanolysis plant. And you've been stuck in a really weak economic environment that hasn't improved since 2022, where volumes in housing, consumer durables are still well below 2019 levels. And even auto is now dropping probably below 2019 levels with the trend this year, we sort of got back to '19 last year. So a lot of opportunity and a lot of pent-up demand with cars 15 years old, appliances getting to their end of life. that's in our future. So we feel very good about demand coming back when we get past one crisis after another and driving utilization benefits, and we're creating our own growth and filling out the methanolysis plant in a weak environment, proving that innovation is a critical success factor for our company and how to win in this industry. And we're holding our price cost stable through all that. So that starts translating into materially improving margins as well as capacity utilization better than last year without the inventory management of last year and cost reduction activities that have been pretty significant in '25 and '26. So no, we feel that we can get the margins back. We just need a stable economy.
Operator: Our next question comes from Arun Viswanathan from RBC Capital Markets.
Arun Viswanathan: I guess a few questions. So first off, just on the spreads environment in CI, you noted some strength. And I guess, obviously, that should continue into Q2. I guess are you seeing any supply issues for your competitors or anything out there that could lead to maybe some permanent rationalization of capacity? And yes, I guess what are you seeing on the supply-demand side for some of the markets in CI?
Mark Costa: It's a great question. I mean, under this sort of economic stress, there are a lot of assets in Europe in the chemical intermediates world that were on the edge of being rationalized and shut down for economic reasons. And obviously, the economic situation has gotten worse for them. And I think that's also true of some assets in Japan and South Korea, where there was a lot of discussion around rationalizations. So I think it's reasonable to expect that some people are going to look at the current situation and say, if I was planning on shutting that asset down 2 years from now, maybe I'd just do it now in this context. I don't have a lot of evidence of that because we're 60 days into a crisis. So everyone is just managing their way through this dynamic, and we don't even know how long the Strait will stay close. So a lot that will factor into that. But I do think global natural gas prices, for example, will likely stay higher for some period of time because even when the Strait opens, Qatar has got to repair all the damage that was done to their fields and their processing capability. You've got oil fields that could get permanently shut in Iran right now if this goes on much longer, a lot of debate around that. You've got just -- it's hard to imagine oil production globally and natural gas production globally suddenly coming back to pre-conflict levels. Not to mention turning oil and natural gas into methanol and naphtha and ammonia and everything else. It's just -- it would be very surprising for just to snap back to those low levels. So I think all of that then just creates more economic pressure on the people on the far right side of the cost curve in those locations that I just mentioned, they're going to have to start considering some rationalization. For sure, we're the low-cost winner in this kind of a context. China has got its own dynamics where we will probably be fine. So I wouldn't expect a lot of rationalization there, except for some maybe their old assets that are not competitive anymore as well, I guess. So yes, we expect to see it, but I can't quote you a bunch of plants that have announced in the last 60 days.
Arun Viswanathan: Okay. I appreciate that. And then just as a quick follow-up. Obviously, historically, your spreads have expanded after inflationary cycles like this. Maybe you can just contextualize the magnitude that we should expect on maybe AM and AFP spread expansion in Q3 and the durability of that. I guess just wondering if you think that these feedstock levels will allow for some more durable pricing power as you move through the year?
William McLain: I think we've talked previously around the high oil environments being positive for Eastman. And as Mark has just highlighted, cost curves over time. In our specialty businesses, obviously, we price off of the value and the relative value, and Mark has highlighted the tension and, I'll call it, price increases and lower value products within the polyester business and how ultimately, that can lead to share and other opportunities as we continue to grow. As we think about the momentum, obviously, we're making the price increases so that we're pricing through the quarter to ensure that our margins are stable. And we'll look to continue to do that in Q3.
Mark Costa: And one thing you have to watch out, we run our business on a dollar per kg basis, not a percent basis. So when you get these kind of significant increases like '21, you also have a denominator math problem. So the prices go up a lot, that goes into the denominator, not just the numerator when you're calculating margins. So you've got to watch out for that. But we'll be very clear about trends around how dollar per kg is going in our margins.
Operator: Our next question comes from Laurence Alexander from Jefferies.
Laurence Alexander: Short term and long term. In the near term, how are you thinking about the rough magnitude of working capital as an impact on your free cash flow conversion this year? And secondly, you mentioned kind of the sort of hitting the quantity limits or the outright shortages. Do you have a sense from your customers where kind of they are expecting or kind of where everybody is waiting to see this actually crack in terms of which end markets feel the outright shortages first and then which ones if shortages do develop, take the longest to fix?
William McLain: So on the working capital front, as we think about the full year impacts, obviously, we built some here in Q1. A lot of that was around planned turnaround. But just as a proxy, I would use the $500 million increase in revenue. And you can take 1/3 of that as I think about how things could balance out, and that could be the full year headwind. And obviously, that could go up or down depending on the timing of the Strait opening, et cetera. But I think $150 million, $200 million roughly.
Mark Costa: Laurence, can you repeat the second question please?
Laurence Alexander: Sure. When you think about where shortages are likely to develop first, when you speak with your customers and they say kind of where the most -- where they're warning you or if they do warn you about potential plant shutdowns, where they're flagging kind of that may happen first or which end markets are -- I mean, obviously, Southeast Asia seems most likely. And then kind of which ones are saying, well, if we shut down, it's going to take us a long time to come back up and fix things because it snarls up the downstream chain too much.
Mark Costa: Yes, those are great questions. I mean there's a question about our competitors and then there's a question about our customers and then the whole supply chain. We're not seeing any disruption yet at the customer level, where they can't get something to finish making the product, just like the semiconductors back in the auto situation back in the 2021 time frame. We are keeping an eye on that, but we haven't had any customers come to us with that problem yet. So it will be sporadic and it will be customer specific. It won't be something you can really foresee is my guess and how that plays out, but we're keeping a very close eye on it. I think that the dynamics around this is obviously pretty volatile, which is why we're not giving full year guidance as you've got a lot of potential upside that we've been talking about. There's obviously end market risk with inflation that has to be all sort of weighed together. But what I'd say overall is we feel really good about our team and how well they performed. When you think about all the dynamics sort of all the way back to COVID to this inflationary environment to a total collapse in discretionary demand in '22 that's stayed with us until now, and then Middle East crisis. And it's a lot to manage. So I'm incredibly proud of how our team manages through all this and finds a way to defend our value propositions. I think the innovation strategy is one that is being proven out to have been a very good choice we made over a decade ago to have ways to defend our value to grow in markets where they're flat or challenged and defend our value in weak times or supply shock times like now. And it's creating a lot of strength in this company. And the circular platform certainly is turning out to be a very good choice that's delivering a lot of growth in this market context. And then, of course, translating all that into cash flow and having a strong balance sheet. So we feel good about how we're navigating with this. We think we have a very meaningful improvement in earnings this year relative to last year. And we're going to focus on what we can control in this chaos to keep delivering for our shareholders every day.
Greg Riddle: As that was the last question, I'll say thanks again for joining us. We appreciate you spending time with Eastman. I hope everybody has a great day.
Operator: This concludes today's call. Thank you for your participation. You may now disconnect.